Getting to Approval: Facilitating Agreements with the FDA
Time: 11:20 am
day: Conference Day Two
Details:
- An overview of the analytical characterization pathway to the clinic
- What really matters with off-targets: Number of sites, amount of off-target editing, oncogenesis?
- How should we account for population diversity when quantifying gene therapies?
